Schneider, B P
Li, L
Shen, F
Miller, K D
Radovich, M
O'Neill, A
Gray, R J
Lane, D
Flockhart, D A
Jiang, G
Wang, Z
Lai, D
Koller, D
Pratt, J H
Dang, C T
Northfelt, D
Perez, E A
Shenkier, T
Cobleigh, M
Smith, M L
Railey, E
Partridge, A
Gralow, J
Sparano, J
Davidson, N E
Foroud, T
Sledge, G W
Article History
Received: 2 May 2014
Revised: 26 June 2014
Accepted: 8 July 2014
First Online: 12 August 2014
Competing interests
: The following authors have received research funds from Genentech/Roach: KDM, JG, CTD, MLS and ER; from Novatis and Amgen: JG, MLS and ER; and from Lilly, Celgene, Morphotek and Sanofi: MLS and ER. BPS is on the advisory board of Genentech (compensated). KDM has received honoraria from Genentech. JS has received consulting fees from Genentech. DAF serves on the scientific education board of the Coriell Institute and Quest Diagnostics and is an active consultant for Clinical Equilibrium Consulting LLC. The remaining authors declare no conflict of interest.